Eli Lilly : LLY

All Eli Lilly Articles

618 Articles

David Moadel | Mar 23, 2026 at 9:34 AM EDT

NVIDIA’s Monday Rebound: What Energy Partnerships and BioNeMo Mean for NVDA Stock

NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) shares are up roughly 2% in Monday morning trading, offering a modest but welcome…

Chris MacDonald | Mar 20, 2026 at 10:02 AM EDT

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

Growth investing has had a choppy start to 2026. The major growth benchmarks are down in the low single digits…

Chris MacDonald | Mar 18, 2026 at 7:00 AM EDT

3 Growth ETFs to Buy in 2026 and Hold Until Your Portfolio Hits 7 Figures

Building a seven-figure portfolio from scratch requires one thing above almost everything else: time in the market, compounded through funds…

David Moadel | Mar 17, 2026 at 12:27 PM EDT

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Eli Lilly (NYSE:LLY | LLY Price Prediction) stock is down 5% in Tuesday afternoon trading, with shares falling to $937…

Joel South | Mar 17, 2026 at 12:25 PM EDT

Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216

Eli Lilly (NYSE:LLY | LLY Price Prediction) shares have pulled back sharply, falling 9% over the past month, and 13%…

Rich Duprey | Mar 16, 2026 at 11:19 AM EDT

Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth

Eli Lilly’s (NYSE:LLY | LLY Price Prediction) GLP-1 therapy Zepbound has become the biggest weight loss drug since its introduction,…

Austin Smith | Mar 11, 2026 at 12:37 PM EDT

Josh Brown: Biotech growth stocks immune to disruption risk

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap biotech:…

Joey Frenette | Mar 4, 2026 at 3:30 PM EST

Forget AI. This Biotech Stock’s Taking Off Right Now

The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is…

Trey Thoelcke | Mar 2, 2026 at 10:40 AM EST

What Smart Money Loves About Lilly

Eli Lilly (NYSE: LLY | LLY Price Prediction) stock has pulled back 2.9% year-to-date to around $1,044, and institutional investors…

Lee Jackson | Feb 27, 2026 at 8:11 AM EST

5 US Blue Chip Giants That Have Paid Dividends for Over 100 Years

Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return. Total…

Lee Jackson | Feb 25, 2026 at 7:57 AM EST

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

Pre-Market Stock Futures: Futures are trading higher this morning, but what a difference a day makes after a “Meltdown Monday.” …

David Beren | Feb 25, 2026 at 7:08 AM EST

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

After finding itself some unwanted attention this week, Novo Nordisk (NYSE:NVO | NVO Price Prediction) has dropped 22% in the…

David Beren | Feb 16, 2026 at 2:00 PM EST

Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

Editor’s note: A prior version of this article stated Eli Lilly and Nvidia had funded a supercomputer, when the commitment…

Joey Frenette | Feb 12, 2026 at 10:00 AM EST

2 Biotech Stocks to Buy as AI Drug Discovery Lifts Off

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age. Undoubtedly, it’s…

Joel South | Feb 12, 2026 at 8:20 AM EST

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)

24/7 Wall St. provides estimates for future stock prices of Eli Lilly from 2026 to 2030 based on projected revenue…

1 2 3 4 … 42

Eli Lilly : LLY

All Eli Lilly Articles

NVIDIA’s Monday Rebound: What Energy Partnerships and BioNeMo Mean for NVDA Stock

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

3 Growth ETFs to Buy in 2026 and Hold Until Your Portfolio Hits 7 Figures

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216

Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth

Josh Brown: Biotech growth stocks immune to disruption risk

Forget AI. This Biotech Stock’s Taking Off Right Now

What Smart Money Loves About Lilly

5 US Blue Chip Giants That Have Paid Dividends for Over 100 Years

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

2 Biotech Stocks to Buy as AI Drug Discovery Lifts Off

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Eli Lilly : LLY

All Eli Lilly Articles

NVIDIA’s Monday Rebound: What Energy Partnerships and BioNeMo Mean for NVDA Stock

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

3 Growth ETFs to Buy in 2026 and Hold Until Your Portfolio Hits 7 Figures

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216

Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth

Josh Brown: Biotech growth stocks immune to disruption risk

Forget AI. This Biotech Stock’s Taking Off Right Now

What Smart Money Loves About Lilly

5 US Blue Chip Giants That Have Paid Dividends for Over 100 Years

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

2 Biotech Stocks to Buy as AI Drug Discovery Lifts Off

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Featured Reads

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk